CAMK1G — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
Pictilisib (SCHEMBL190812)	1.00	1/20
SCHEMBL1128220	1.00	1/20
SCHEMBL190513	0.95	1/20
SCHEMBL31205	0.88	1/20
SCHEMBL190211	0.87	1/20
SCHEMBL1128513	0.86	1/20
SCHEMBL1128074	0.85	1/20
SCHEMBL958991	0.84	1/20
SCHEMBL1087562	0.83	1/20
SCHEMBL190273	0.82	1/20
SCHEMBL190427	0.82	1/20
SCHEMBL1088395	0.82	1/20
SCHEMBL1300395	0.82	1/20
SCHEMBL1128065	0.81	1/20
SCHEMBL1128216	0.81	1/20
SCHEMBL1128228	0.81	1/20
Trimethylammonium (SCHEMBL1128252)	0.81	1/20
SCHEMBL189487	0.81	1/20
SCHEMBL189951	0.81	1/20
SCHEMBL189952	0.81	1/20

Clinical trials — most relevant to CAMK1G by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
COMS for Chronic Ulcers Treatment	PHASE4	RECRUITING
Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients	PHASE3	ACTIVE_NOT_RECRUITING
Evaluate Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients	PHASE3	COMPLETED
The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients	PHASE1/PHASE2	WITHDRAWN
Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease	PHASE2	COMPLETED
Anti-Estrogens - A Potential Treatment for Bipolar Affective Disorder in Women?	PHASE2	COMPLETED
Autologous Cytokine Induced Killer Cells (CIK) for Chronic Myeloid Leukemia (CML) Patients on Standard Drug Therapy	PHASE2	COMPLETED
Bioequivalence Study of Tacrolimus in Healthy Volunteers	PHASE1	COMPLETED
Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed Patients	PHASE1	COMPLETED
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma	PHASE1	COMPLETED
Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)	EARLY_PHASE1	RECRUITING
D-aspartate and Therapeutic Exercise	EARLY_PHASE1	UNKNOWN
Epithelioid Haemangioendothelioma Observational Study	nan	RECRUITING
Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia	nan	RECRUITING
Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia	nan	RECRUITING
Calmodulin Gene Mutations in Patients With Ventricular Arrhythmia of Unknown Origin - A Screening Study	nan	WITHDRAWN
Abnormalities in the Effects of Insulin and Exercise on Glucose- and Lipid Metabolism in Obesity and Type 2 Diabetes	nan	COMPLETED
Human Epilepsy Genetics--Neuronal Migration Disorders Study	nan	RECRUITING
Ischemic Preconditioning to Prevent Acute Kidney Injury	nan	COMPLETED
Role of Nitric Oxide in Diabetic Patients With Erectile Dysfunction	nan	COMPLETED
Assessing Bone Calcium Content in Children With Kidney Disease Treated With Two Different Medicines	nan	UNKNOWN
Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease	nan	UNKNOWN
Biomarkers of CASH	nan	ACTIVE_NOT_RECRUITING
Relationship of Gestational Age and Urine Concentration of S100B in Preterm and Term Infants in the First Week of Life	nan	COMPLETED
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms	nan	COMPLETED
Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory	nan	COMPLETED
Multicenter Study of Patients With SHANK3 Mutations: Identification of Genes Modificators in Phelan-McDermid Syndrome (EUQ13)	nan	NOT_YET_RECRUITING
Role of Amino Acids and Genetic Disorder in Pathogenesis of Heart Failure	nan	UNKNOWN
Genetic Variants Associated With Adolescent Suicide Attempts	nan	COMPLETED
Urine Concentration of S100B in Extremely Premature Infants	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a CAMK1G binder may also engage these)

Protein	Name	Similarity
Q91VB2	—	1.000	Q91VB2 →
Q7TNJ7	—	0.999	Q7TNJ7 →
P13234	—	0.991	P13234 →
DYRK4	Dual specificity tyrosine-phosphorylation-regulated kinase 4	0.988	landscape →
P07934	—	0.987	P07934 →
Q66I46	—	0.986	Q66I46 →
Q8BHI9	—	0.986	Q8BHI9 →
P08414	—	0.986	P08414 →
Q6PGN3	—	0.986	Q6PGN3 →
Q8BRK8	—	0.985	Q8BRK8 →
O19111	—	0.985	O19111 →
Q8VBY2	—	0.985	Q8VBY2 →
CAMK4	Calcium/calmodulin-dependent protein kinase type IV	0.985	landscape →
MKNK1	MAP kinase-interacting serine/threonine-protein kinase 1	0.985	landscape →
O08605	—	0.985	O08605 →
Q9QYZ6	—	0.985	Q9QYZ6 →
Q9QYZ4	—	0.984	Q9QYZ4 →
Q6PFQ0	—	0.984	Q6PFQ0 →
Q8C0V7	—	0.984	Q8C0V7 →
PHKG2	Phosphorylase b kinase gamma catalytic chain, liver/testis isoform	0.984	landscape →
Q852Q2	—	0.984	Q852Q2 →
DCLK1	Serine/threonine-protein kinase DCLK1	0.984	landscape →
Q39030	—	0.984	Q39030 →
Q641K5	—	0.983	Q641K5 →
RPS6KB1	Ribosomal protein S6 kinase beta-1	0.983	landscape →
A2KF29	—	0.983	A2KF29 →
A5GFW1	—	0.983	A5GFW1 →
Q8BSK8	—	0.983	Q8BSK8 →
Q9Z2R9	—	0.983	Q9Z2R9 →
Q68UT7	—	0.983	Q68UT7 →